BioForce Nanosciences Holdings Inc
bioforceeclipse.comWhat Do They Do?
Sells a private-label vitamin and mineral powder supplement for active consumers, targeting retail stores and online buyers.
10-K for FY2025, filed Apr 15, 2026Currently, the Company BioForce Eclipse, a private label brand powder supplements. The product is a mixture of amino acids, key vitamins…View ↗
BioForce recently changed its business plan and it is in the process of establishing a dynamic marketing campaign to achieve brand…View ↗
Nutrition retailers, grocery stores, retail pharmacies, and online stores, like Amazon, will be important channels for the Company's…View ↗
How Do They Make Money?
It earns money from vitamin supplement product sales; sales are counted when the goods are transferred to customers.
10-K for FY2025, filed Apr 15, 2026The Company recognizes revenue and cost of goods sold from product sales or services rendered when control of the promised goods are…View ↗
$17.8K
-
10-K for FY2020, filed Feb 16, 2021
$17.8K ↗
Who Are Their Customers?
The company targets retailers, supermarkets and gyms through business-to-business outreach, and plans direct sales on its website.
10-K for FY2025, filed Apr 15, 2026BioForce recently changed its business plan and it is in the process of establishing a dynamic marketing campaign to achieve brand…View ↗
The Company plans to offer its products for direct sales on its website at www.bioforceeclipse.com.View ↗
The Company will seek out retail sales opportunities with gyms, health clubs, and fitness centers with incentive base sales agreements…View ↗
Do Revenues Turn Into Profits?
No. It lost $46.5K in FY2019.
10-K for FY2020, filed Feb 16, 2021
10-K for FY2020, filed Feb 16, 2021
−$46.5KView ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 10, 2026
$238.7KView ↗
- ▲ Now profitable
- vs −$122.8K in Q2 FY2025
-
Aug 14, 2026
Richard Kaiser was appointed interim CEO
Sources
8-K, filed Aug 14, 2026
On June 17, 2026, the Company’s Board of Directors appointed Richard Kaiser as the Company’s interim Chief Executive Officer (CEO). Mr.…View ↗
-
Jul 7, 2026
Federal approval gave BioForce oil and gas exploration rights
The approval covered eleven leases in the White River Valley, Nevada.
Sources
8-K, filed Jul 7, 2026
As previously reported, Bioforce Nanoscience, Inc. (Bioforce or BFNH) received the assignment of federal oil and gas leases from Natural…View ↗
-
Jul 1, 2026
BioForce announced a shift from supplements to oil and gas
The company described the leases and its exploration plans as the first steps in that shift.
Sources
8-K, filed Jul 1, 2026
The Company previously announced a strategic pivot from vitamin supplement operations to oil and gas exploration and production. Ownership…View ↗
-
Jun 18, 2026
Nexus acquired the controlling stake as co-CEOs resigned
Nexus bought the seller’s controlling shares, and both co-CEOs resigned.
Sources
8-K, filed Jun 18, 2026
April 15, 2026, Merle Ferguson (“Seller”), a current Director of the Company sold 26,700,000 shares of his common stock in the Company to…View ↗
Loading...
